• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Catalog Number TF-21A
Device Problems Patient-Device Incompatibility (2682); Material Split, Cut or Torn (4008); Central Regurgitation (4068)
Patient Problem Aortic Valve Insufficiency/ Regurgitation (4450)
Event Date 12/18/2023
Event Type  Injury  
Event Description
It was reported that on 20 may 2016, a 21mm trifecta valve was successfully implanted.Sometime in (b)(6) 2023, the patient returned symptomatic with aortic regurgitation grade 2.On (b)(6) 2023, the trifecta valve was explanted and a replacement 23mm epic valve was successfully implanted.In the extracted trifecta, there was a tear in the commissural part of left-coronary cusp (lcc) and right-coronary cusp (rcc), and pannus was tensed in inflow side in the whole circumference.The explanted valve was marked with a blue polyethylene suture on the leaflet at lcc.The patient's condition is stable.
 
Manufacturer Narrative
The device is expected to be returned for evaluation.It has not yet been received.A follow-up report will be submitted with all additional relevant information.
 
Manufacturer Narrative
Explant due to symptoms of aortic regurgitation was reported.It was also reported that the explanted valve had a tear in the commissural part of left-coronary cusp (lcc) and right-coronary cusp (rcc), and pannus on the circumferential inflow side.The investigation found that leaflets 2 and 3 were torn.There was circumferential fibrous pannus ingrowth on the inflow surface, with narrowing of inflow diameter.Leaflet 3 had partial thickness incision.No acute inflammation or significant calcifications were present.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.In the absence of any calcification at the tear site or evidence for infection, the reported event is consistent with a non-calcific leaflet tear.A non-calcific leaflet tear is a form of structural valve deterioration (svd), which is a well-known complication from valve replacement surgery.A non-calcific leaflet tear is commonly attributed to increased operational leaflet stress but may also be related to biological factors which result in tissue degeneration characterized by loss of collagen.In this case, histological evaluation did demonstrate degenerative changes at the tear site, which could have contributed to the formation of the tear.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SJM TRIFECTA VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ST. JUDE MEDICAL #3014918977
edificio #44 calle 0, ave. 2
el coyol alajuela 1897- 4050
CS   1897-4050
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key18485761
MDR Text Key332568914
Report Number2135147-2024-00170
Device Sequence Number1
Product Code LWR
UDI-Device Identifier05414734052023
UDI-Public05414734052023
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P100029
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/06/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/21/2017
Device Catalogue NumberTF-21A
Device Lot Number5270576
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/10/2024
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/18/2023
Initial Date FDA Received01/10/2024
Supplement Dates Manufacturer Received03/05/2024
Supplement Dates FDA Received03/06/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/23/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age73 YR
Patient SexFemale
Patient Weight50 KG
-
-